🇺🇸 FDA
Patent

US 11564916

Pharmaceutical composition and administrations thereof

granted A61KA61K31/44A61K31/47

Quick answer

US patent 11564916 (Pharmaceutical composition and administrations thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K31/44, A61K31/47, A61K9/0053, A61K9/1635